ClinicalTrials.gg
CompletedNCT02087930MATFAUpdated Sep 2, 2026

Microbiota as Potential Target for Food Allergy

An observational study in Cow Milk Allergy, sponsored by Federico II University. Completed at 1 site in Italy. Open to participants aged 6 Months to 12 Months. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Federico II University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Ages
6 Months to 12 Months
Sex
All
01

Study summary

Food allergy (FA) derives from a dysregulation of oral tolerance mechanisms. Studies suggest a crucial role for enteric microflora in oral tolerance development. An altered composition of intestinal microflora results in an unbalanced local and systemic immune response to food allergens. There are qualitative and quantitative differences in gut microbiota composition in children with food allergy. These findings support the concept that specific beneficial bacteria from human intestinal microflora, designated probiotics, could restore intestinal microflora homeostasis and prevent or treat FA.

02

Conditions studied

  • Cow Milk Allergy

Browse trials for

03

In context

Milk Hypersensitivity

147 studies on the registry are indexed under Milk Hypersensitivity; 26 are open to participants now.

This study's enrollment of 600 is above the median of 102 across 45 observational studies indexed under Milk Hypersensitivity.

Browse Milk Hypersensitivity studies →

Lead sponsor

Federico II University is the lead sponsor of 366 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children with cow's milk allergy
  • age 6-12 months

Exclusion criteria

Exclusion Criteria:

  • concomitant chronic systemic diseases
  • congenital cardiac defects
  • active tuberculosis
  • diseases
  • immunodeficiency
  • chronic inflammatory bowel diseases
  • celiac disease, cystic fibrosis
  • metabolic diseases
  • chronic pulmonary diseases
  • malformations of the gastrointestinal tract
  • suspected eosinophilic esophagitis or eosinophilic enterocolitis
  • suspected food-protein-induced enterocolitis syndrome.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Cow milk allergy children

    Children affected by Immunoglobulin E medited cow milk allergy

  • healthy control

    healthy infants

06

What researchers measure

Primary outcomes

  1. Composition and function gut microbiota in children with cow milk allergy and healthy children

    Time frame: Change from baseline at 6 and 12 months

Secondary outcomes

  1. Composition and function gut microbiota comparing cow milk allergy Italian and cow milk allergy children of other countries

    Time frame: Change from baseline at 6 and 12 months

  2. Composition and function gut microbiota comparing healthy Italian and healthy children of other countries

    Time frame: Change from baseline at 6 and 12 months

07

Study locations

1 site
  • University of Naples Federico II
    Naples, Naples 80131, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02087930
Responsible party
Roberto Berni Canani, MD, PhD (MD, PhD, Federico II University) — Principal investigator
First posted
Mar 14, 2014
Start date
Mar 2013
Primary completion
May 2020
Completion
Sep 2020
Last update
Sep 2, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion